JP2025502891A5 - - Google Patents
Info
- Publication number
- JP2025502891A5 JP2025502891A5 JP2024543040A JP2024543040A JP2025502891A5 JP 2025502891 A5 JP2025502891 A5 JP 2025502891A5 JP 2024543040 A JP2024543040 A JP 2024543040A JP 2024543040 A JP2024543040 A JP 2024543040A JP 2025502891 A5 JP2025502891 A5 JP 2025502891A5
- Authority
- JP
- Japan
- Prior art keywords
- product according
- pharmaceutical product
- satralizumab
- dose
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263300893P | 2022-01-19 | 2022-01-19 | |
| US63/300,893 | 2022-01-19 | ||
| PCT/JP2023/001270 WO2023140269A1 (en) | 2022-01-19 | 2023-01-18 | Treatment of autoimmune encephalitis with satralizumab |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502891A JP2025502891A (ja) | 2025-01-28 |
| JP2025502891A5 true JP2025502891A5 (cg-RX-API-DMAC7.html) | 2026-01-14 |
Family
ID=87348849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543040A Pending JP2025502891A (ja) | 2022-01-19 | 2023-01-18 | 自己免疫性脳炎のサトラリズマブによる治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250127891A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4466018A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025502891A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240145472A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118900699A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023209259A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3243067A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL314213A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024008835A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202337495A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023140269A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4793360A2 (en) | 2006-03-31 | 2026-08-19 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
| TWI654203B (zh) | 2010-11-30 | 2019-03-21 | Chugai Seiyaku Kabushiki Kaisha | 具有鈣依存性的抗原結合能力之抗體 |
| EP3620531A4 (en) | 2017-05-02 | 2021-03-17 | National Center of Neurology and Psychiatry | METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS |
| TWI822728B (zh) | 2018-01-31 | 2023-11-21 | 加藤元一 | 含有il-6抑制劑的哮喘治療劑 |
| AU2020259884A1 (en) | 2019-04-17 | 2021-10-07 | Chugai Seiyaku Kabushiki Kaisha | Therapeutic agent for urological cancer which is characterized by being administered with il-6 inhibitor and ccr2 inhibitor in combination |
| US12558423B2 (en) | 2020-05-29 | 2026-02-24 | Chugai Seiyaku Kabushiki Kaisha | Antibody-containing formulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2505603C2 (ru) | 2007-09-26 | 2014-01-27 | Чугаи Сейяку Кабусики Кайся | Антитело против рецептора il-6 |
| TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| WO2010065116A2 (en) | 2008-12-02 | 2010-06-10 | The Trustees Of The University Of Pennsylvania | The use of il-27-p28 to antagonize il-6 mediated signaling |
| TWI759261B (zh) | 2015-02-27 | 2022-04-01 | 日商中外製藥股份有限公司 | Il-6受體抗體用於製備醫藥組成物的用途 |
| JPWO2020202839A1 (cg-RX-API-DMAC7.html) * | 2019-03-29 | 2020-10-08 |
-
2023
- 2023-01-18 TW TW112102365A patent/TW202337495A/zh unknown
- 2023-01-18 US US18/729,273 patent/US20250127891A1/en active Pending
- 2023-01-18 WO PCT/JP2023/001270 patent/WO2023140269A1/en not_active Ceased
- 2023-01-18 KR KR1020247027265A patent/KR20240145472A/ko active Pending
- 2023-01-18 MX MX2024008835A patent/MX2024008835A/es unknown
- 2023-01-18 AU AU2023209259A patent/AU2023209259A1/en active Pending
- 2023-01-18 CN CN202380028068.8A patent/CN118900699A/zh active Pending
- 2023-01-18 IL IL314213A patent/IL314213A/en unknown
- 2023-01-18 JP JP2024543040A patent/JP2025502891A/ja active Pending
- 2023-01-18 EP EP23743263.8A patent/EP4466018A4/en active Pending
- 2023-01-18 CA CA3243067A patent/CA3243067A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Egan et al. | Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine | |
| KR101900520B1 (ko) | 복합 조성물 | |
| JP2015187125A5 (cg-RX-API-DMAC7.html) | ||
| US5817699A (en) | Process for the preparation of ketamine ointment | |
| Present | the efficacy of infliximab in Crohn’s disease—healing of fistulae | |
| JP2024529434A5 (cg-RX-API-DMAC7.html) | ||
| JP2025148449A5 (cg-RX-API-DMAC7.html) | ||
| Tumani | Corticosteroids and plasma exchange in multiple sclerosis | |
| Van der Bijl et al. | Rectal ketamine and midazolam for premedication in pediatric dentistry | |
| Rommer et al. | Repurposing multiple sclerosis drugs: a review of studies in neurological and psychiatric conditions | |
| Vermersch et al. | Mycophenolate mofetil and neurological diseases | |
| EP3701956B1 (en) | Prophylactic and/or therapeutic agent for dementia | |
| Trobe | High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial | |
| US20040147433A1 (en) | Neuroimmunophilins for selective neuronal radioprotection | |
| AU766095B2 (en) | Neuroimmunophilins for selective neuronal radioprotection | |
| Huang et al. | Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study | |
| CN108014337A (zh) | 一种用于治疗眼自身免疫性葡萄膜炎的药物组合物 | |
| El Ghazaly et al. | Use of Oral Mini Pulse Dexamethasone in Vitiligo Patients | |
| Klein | Discontinuation of benzodiazepines in patients with anxiety disorders: a focus on alprazolam and alprazolam extended release | |
| CN114129722B (zh) | 注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途 | |
| Sarmiento et al. | Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia | |
| CN108014336B (zh) | 一种用于治疗眼自身免疫性葡萄膜炎的药物组合物 | |
| PILLING et al. | Electroshock therapy of a depressed patient with complete heart block | |
| RU2233664C2 (ru) | Способ лечения красного плоского лишая | |
| NZ781127B2 (en) | Mirikizumab for use in a method of treating crohn's disease |